financetom
Business
financetom
/
Business
/
Enbridge Outlines Strategic Priorities, Financial Outlook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Enbridge Outlines Strategic Priorities, Financial Outlook
Mar 6, 2024 4:48 AM

07:28 AM EST, 03/06/2024 (MT Newswires) -- Enbridge Inc. ( ENB ) outlined Wednesday its strategic priorities and financial outlook as the company hosts an investor conference today in New York.

Enbridge ( ENB ) extended its average annual growth rate through 2026 of 7%-9% for adjusted EBITDA, 4%-6% for EPS and 3% for distributable cash flow (DCF) per share.

The company also reaffirmed its average annual growth rate of 5% post 2026 for adjusted EBITDA, DCF per share and adjusted EPS.

In addition, Enbridge ( ENB ) reaffirmed its EBITDA and DCF per share guidance for 2024.

Enbridge ( ENB ) said its acquisitions of US gas utilities announced in September 2023 are expected to close at different times during 2024 and are not included in its 2024 financial guidance.

The company also plans to invest about $3 billion annually in low-risk natural gas utility infrastructure, inclusive of the assumed capital for its acquisitions.

"At Enbridge ( ENB ), we're building out our integrated infrastructure super systems, to enable the continued delivery of energy in a planet-friendly way, everywhere people need it," President and CEO Greg Ebel said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vertex Pharmaceuticals Discloses 'Positive' Data From Phase 1/2 Trial of VX-880 to Treat Type 1 Diabetes
Vertex Pharmaceuticals Discloses 'Positive' Data From Phase 1/2 Trial of VX-880 to Treat Type 1 Diabetes
Jun 21, 2024
04:22 PM EDT, 06/21/2024 (MT Newswires) -- Vertex Pharmaceuticals ( VRTX ) said Friday it has seen positive new results from a phase 1/2 trial of VX-880 to treat people with type 1 diabetes with impaired hypoglycemic awareness and severe hypoglycemic events. Updated results on 12 people who were given the full dose of VX-880 as a single infusion are...
SLR Investment Insider Bought Shares Worth $399,500, According to a Recent SEC Filing
SLR Investment Insider Bought Shares Worth $399,500, According to a Recent SEC Filing
Jun 21, 2024
04:22 PM EDT, 06/21/2024 (MT Newswires) -- Roberts Andrea Colvin, Director, on June 14, 2024, executed a purchase for 25,000 shares in SLR Investment ( SLRC ) for $399,500. Following the Form 4 filing with the SEC, Roberts Andrea Colvin has control over a total of 25,000 shares of the company, with 25,000 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1418076/000095017024076256/xslF345X03/ownership.xml Price:...
Amcon Distributing Completes Acquisition of Richmond Master Distributors
Amcon Distributing Completes Acquisition of Richmond Master Distributors
Jun 21, 2024
04:29 PM EDT, 06/21/2024 (MT Newswires) -- Amcon Distributing ( DIT ) said late Friday it completed the acquisition of Richmond Master Distributors. Financial details weren't provided. ...
Sonic Automotive says CDK's cyber outage impacted its dealer management systems
Sonic Automotive says CDK's cyber outage impacted its dealer management systems
Jun 21, 2024
June 21 (Reuters) - Sonic Automotive ( SAH ) said on Friday that the ongoing CDK cyber outage has impacted its dealer management systems. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved